Lutheran Medical Center in New York Invests in State-of-the-Art Masimo Patient SafetyNet(TM) System to Help Keep Patients Safer
2010年2月26日 - 1:00AM
PRニュース・ワイアー (英語)
System Noninvasively Monitors Physiology of up to 80 Patients on
Four Floors -- Helping Clinicians Improve Safety, Speed Recoveries,
Increase Efficiencies, and Reduce the Cost of Care IRVINE, Calif.,
Feb. 25 /PRNewswire-FirstCall/ -- Lutheran Medical Center in
Brooklyn, New York and Masimo (NASDAQ:MASI), the inventor of Pulse
CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse
oximetry, today announced the installation of the Masimo Patient
SafetyNet system, an advanced noninvasive remote monitoring and
wireless clinician notification system designed to help hospitals
avoid preventable patient deaths and injuries associated with
failure to rescue events -- one of today's most common medical
errors.(1) Masimo Patient SafetyNet allows clinicians at Lutheran
Medical Center to noninvasively, continuously, and remotely monitor
multiple physiological parameters -- including arterial oxygen
saturation, respiration rate, hemoglobin levels, and pulse rate --
and have changes that signal early patient distress or
deterioration automatically sent via pager to a qualified
caregiver. Earlier detection may facilitate earlier interventions,
which has been shown to help improve outcomes. In a
recently-published landmark study at Dartmouth-Hitchcock Medical
Center, the Masimo Patient SafetyNet system was shown to help
decrease distress codes and activations by 65%, and intensive care
unit (ICU) transfers by 48% -- resulting in an annualized savings
of 135 ICU days.(2) "Patient SafetyNet provides the peace of mind
that comes from knowing that it is always watching over our
patients -- continuously monitoring their physiology when we can't
be at the bedside to do it," said Helen Buckel, RN, Nurse Manager,
Lutheran Medical Center. "Even when we leave the room, we know that
little finger sensor the patient wears is doing an enormous job.
The moment the patient encounters trouble or a life-threatening
event occurs, the system immediately alerts us, so precious seconds
aren't wasted and lifesaving help is just a beat away." When a
patient is in distress, specific, detailed physiological data is
sent directly to assigned clinicians, enabling them to intervene
before the situation becomes critical and requires more acute
levels of care. This is particularly important for post-surgical
patients who are at increased risk of injury or death resulting
from the respiratory depression effects of medications used for
sedation and pain management. Masimo Executive Vice President of
Medical Affairs, Michael O'Reilly, MD, stated, "Each year healthy
patients admitted for routine procedures become failure to rescue
statistics because an adverse event was not recognized in time to
save them. Masimo Patient SafetyNet significantly expands the
patient monitoring capabilities available to Lutheran clinicians,
helping to improve patient outcomes and decrease costs -- two
things every hospital wants and needs." (1) "The Sixth Annual
HealthGrades Patient Safety in American Hospitals Study" April
2009.
http://www.healthgrades.com/media/DMS/pdf/PatientSafetyInAmericanHospitalsStud
y2009.pdf (2) Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan
P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on
Rescue Events and Intensive Care Unit Transfers: A Before-and-After
Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue
2.
http://journals.lww.com/anesthesiology/Abstract/publishahead/Impact_of_Pulse_O
ximetry_Surveillance_on_Rescue.99692.aspx About Lutheran Medical
Center A Level I Trauma Center and Stroke Center, Lutheran Medical
Center (LMC) has cared for Brooklyn communities since 1883. As a
full service 476-bed teaching hospital, LMC is the hub of Lutheran
HealthCare, a network of primary, acute and long-term care centers
in southwest Brooklyn. The LMC Surgical Weight Loss Institute is
the only program in Brooklyn to be designated as a Center of
Excellence by the American Society for Bariatric Surgery while also
holding a Level 1 Accreditation from the American College of
Surgeons. Learn more about LMC and its commitment to patient care
excellence, community service, health education and research online
at http://www.lutheranmedicalcenter.com/. About Masimo Masimo
(NASDAQ:MASI) develops innovative monitoring technologies that
significantly improve patient care -- helping solve "unsolvable"
problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET®, which virtually
eliminated false alarms and increased pulse oximetry's ability to
detect life-threatening events. More than 100 independent and
objective studies demonstrate Masimo SET provides the most reliable
SpO2 and pulse rate measurements even under the most challenging
clinical conditions, including patient motion and low peripheral
perfusion. In 2005, Masimo introduced Masimo Rainbow SET® Pulse
CO-Oximetry(TM), allowing noninvasive and continuous monitoring of
blood constituents that previously required invasive procedures,
including total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and PVI®, in
addition to SpO2, pulse rate, and perfusion index (PI). In 2009,
Masimo introduced Masimo Rainbow SET® Acoustic Monitoring(TM), the
first-ever noninvasive and continuous monitoring of acoustic
respiration rate (RRa). Masimo's Rainbow platform offers a
breakthrough in patient safety by helping clinicians detect
life-threatening conditions and helping guide treatment options.
Founded in 1989, Masimo has the mission of "Improving Patient
Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring
to New Sites and Applications." Additional information about Masimo
and its products may be found at http://www.masimo.com/. Forward
Looking Statements This press release includes forward-looking
statements as defined in Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934, in
connection with the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on current
expectations about future events affecting us and are subject to
risks and uncertainties, all of which are difficult to predict and
many of which are beyond our control and could cause our actual
results to differ materially and adversely from those expressed in
our forward-looking statements as a result of various risk factors,
including, but not limited to: risks related to our belief that
Masimo Patient SafetyNet will provide an effective early warning
system of a patient's deteriorating physiological condition in
real-time for all patients to enable timely rescue and increase
patient safety, risks related to our belief that Masimo SET and
Masimo Rainbow SET measurements and alarms will provide sufficient
sensitivity and specificity to detect physiological abnormalities
and potentially life-threatening conditions in real-time for all
patients, risks related to our assumptions regarding the
repeatability of clinical results, as well as other factors
discussed in the "Risk Factors" section of our most recent reports
filed with the Securities and Exchange Commission ("SEC"), which
may be obtained for free at the SEC's website at
http://www.sec.gov/. Although we believe that the expectations
reflected in our forward-looking statements are reasonable, we do
not know whether our expectations will prove correct. All
forward-looking statements included in this press release are
expressly qualified in their entirety by the foregoing cautionary
statements. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of today's date. We
do not undertake any obligation to update, amend or clarify these
forward-looking statements or the "Risk Factors" contained in our
most recent reports filed with the SEC, whether as a result of new
information, future events or otherwise, except as may be required
under the applicable securities laws. Media Contacts: Dana Banks
Nicole Hyland Masimo Corporation Lutheran Medical Center (949)
297-7348 (718) 630-7414 Masimo, SET, Signal Extraction Technology,
Improving Outcomes and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC,
SpCO, SpMet, PVI, RRa, Radical-7, Rad-87, Rad-57, Rad-9, Rad-8,
Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or
registered trademarks of Masimo Corporation. DATASOURCE: Masimo
Corporation CONTACT: Dana Banks of Masimo Corporation,
+1-949-297-7348, ; or Nicole Hyland of Lutheran Medical Center,
+1-718-630-7414, Web Site: http://www.masimo.com/
http://www.lutheranmedicalcenter.com/
Copyright